Overall, TSP1 has emerged as a multifaceted regulator of metabolic, inflammatory, and thrombotic pathways, offering promise as a therapeutic target for obesity-associated conditions. Here, THBS1 is linked to obesity due to melanocortin 4 receptor deficiency.